Literature DB >> 23662688

Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center.

Janet M Lim1, Joshua H Hou, Ramesh M Singa, Vinay K Aakalu, Pete Setabutr.   

Abstract

PURPOSE: In patients referred with blepharoptosis, the possibility of an underlying systemic cause for their ptosis can warrant a more detailed evaluation. The purpose of this study is to determine both the incidence and demographic characteristics associated with different types of ptosis in patients referred to the oculoplastics division at a tertiary care center.
METHODS: A retrospective chart review was performed on all patients referred to the oculoplastics division between 2007 and 2010. Final etiology for each patient's ptosis was determined based on history, standard eyelid measurements, and ancillary testing. Based on etiology, ptosis was categorized as aponeurotic, neurogenic, myogenic, traumatic, congenital, or mechanical. Demographics, including median age and sex were analyzed for patients in each category of ptosis.
RESULTS: Of the 251 patients, aponeurotic ptosis was the most common type of ptosis (60.2%), followed by traumatic (11.2%), congenital (10.4%), mechanical (8.8%), neurogenic (5.6%), and myogenic (4.0%). Of the neurogenic group, 35.7% of patients had cranial nerve 3 (CN 3) palsy, 28.6% had myasthenia gravis, 14.3% had aberrant regeneration, and 7.1% had Horner's syndrome. Thirty percent of the myogenic group had chronic progressive external ophthalmoplegia (CPEO). The congenital group had the youngest median age (10.5 years), yet the aponeurotic group had the oldest (62 years).
CONCLUSIONS: A significant proportion of patients referred with ptosis had more serious conditions such as neurogenic or myogenic ptosis. Thus, clinicians should maintain a high degree of suspicion and thoroughly evaluate all patients with ptosis in order to properly assess for underlying systemic associations.

Entities:  

Mesh:

Year:  2013        PMID: 23662688      PMCID: PMC4123537          DOI: 10.3109/01676830.2013.788673

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  11 in total

1.  Congenital ptosis and blefarophimosis: retrospective analysis of the effectiveness of correction with levator resection and frontalis suspension.

Authors:  R Gazzola; E Piozzi; A L Lanfranchi; F W Baruffaldi Preis
Journal:  Pediatr Med Chir       Date:  2011 May-Jun

Review 2.  Management of myasthenic patients with thymoma.

Authors:  Marcin Zieliński
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

3.  Ocular trauma epidemiology: 10-year retrospective study.

Authors:  Archana Pandita; Michael Merriman
Journal:  N Z Med J       Date:  2012-01-20

Review 4.  A systematic review of diagnostic studies in myasthenia gravis.

Authors:  Michael Benatar
Journal:  Neuromuscul Disord       Date:  2006-06-21       Impact factor: 4.296

5.  Highly active antiretroviral therapy-associated ptosis in patients with human immunodeficiency virus.

Authors:  Rona Z Silkiss; Han Lee; Vincent L Gills Ray
Journal:  Arch Ophthalmol       Date:  2009-03

Review 6.  Congenital and acquired blepharoptosis.

Authors:  P J Sakol; G Mannor; B M Massaro
Journal:  Curr Opin Ophthalmol       Date:  1999-10       Impact factor: 3.761

Review 7.  The mechanistic classification of ptosis.

Authors:  B R Frueh
Journal:  Ophthalmology       Date:  1980-10       Impact factor: 12.079

8.  Etiological pattern of blepharoptosis among patients presenting in teaching hospital.

Authors:  R Thapa; P C Karmacharya; B P Nepal
Journal:  JNMA J Nepal Med Assoc       Date:  2006 Apr-Jun       Impact factor: 0.406

9.  Correction of myopathic blepharoptosis by check ligament suspension: clinical evaluation of 89 eyelids.

Authors:  Fabio Santanelli; Guido Paolini; Luca Francesco Renzi; Benedetto Longo; Marco Pagnoni; Hans Holmström
Journal:  J Plast Surg Hand Surg       Date:  2011-09

10.  Blepharoptosis in Ibadan, Nigeria.

Authors:  A M Baiyeroju; O M Oluwatosin
Journal:  West Afr J Med       Date:  2003-09
View more
  13 in total

1.  Eyelid ptosis.

Authors:  Colin W McInnes; Matthew Lee-Wing
Journal:  CMAJ       Date:  2015-05-25       Impact factor: 8.262

Review 2.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

3.  The significance of minimal adjustments in the Muller's muscle and conjunctiva resection procedure to achieve the phenylephrine result.

Authors:  Rakesh M Patel; Alice Z Chuang; Juliana Sartori; Vinay K Aakalu; Allen M Putterman; Pete Setabutr
Journal:  Orbit       Date:  2015-03-25

4.  Efficacy of brow suspension with autogenous fascia lata in simple congenital ptosis.

Authors:  Farhan Ali; Muhammad Saim Khan; Muhammad Sharjeel; Zaheer Ud Din; Bilal Murtaza; Asfandyar Khan
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

5.  Clinical and Demographic Characteristics of Blepharoptosis in Korea: A 24-year Experience including 2,328 Patients.

Authors:  Youn Gon Lee; Byeong Jae Son; Ka Hyun Lee; Sang Yeul Lee; Chang Yeom Kim
Journal:  Korean J Ophthalmol       Date:  2018-08

6.  Synchronous Surgical Treatment of Lower Eyelid Involutional Entropion and Ptosis.

Authors:  D Vasakos; E Nakos; C Sioulis
Journal:  Case Rep Ophthalmol Med       Date:  2018-11-11

7.  Traumatic Ptosis: Evaluation of Etiology, Management and Prognosis.

Authors:  Sarah Mireles Jacobs; Ariel J Tyring; Arash J Amadi
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec

8.  A clinical decision model based on machine learning for ptosis.

Authors:  Xuefei Song; Weilin Tong; Guangtao Zhai; Huifang Zhou; Chaoyu Lei; Jingxuan Huang; Xianqun Fan
Journal:  BMC Ophthalmol       Date:  2021-04-09       Impact factor: 2.209

9.  Objective quantification of the impact of blepharoplasty on the superior visual field.

Authors:  Hyodong Kim; Sanghun Lee; Daegu Son; Hyeonjung Yeo
Journal:  Arch Plast Surg       Date:  2022-01-15

10.  Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

Authors:  Jason Bacharach; David L Wirta; Robert Smyth-Medina; Michael S Korenfeld; Shane R Kannarr; Shane Foster; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.